Adverse drug events in emergency department population: A prospective Italian study

Pharmacoepidemiology and Drug Safety

Volumn 14, Issue 5, 2005, Pages 333-340

  Trifirò, Gianluca ^a   Calogero, Gianfranco ^a   Ippolito, Francesca Menniti ^b   Cosentino, Mario ^c   Giuliani, Rodolfo ^d   Conforti, Anita ^e   Venegoni, Mauro ^f   Mazzaglia, Giampiero ^a,g   Caputi, Achille P ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY OF INSUBRIA   (Italy)

^d ASTRAZENECA   (United Kingdom)

^e UNIVERSITY OF VERONA   (Italy)

^f FATEBENEFRATELLI HOSPITAL   (Italy)

^g Italian College of General Practitioners   (Italy)

Author keywords

Adverse drug event; Drug history; Emergency department; Hospitalisation

Indexed keywords

ACETYLSALICYLIC ACID; ALPRAZOLAM; AMBROXOL; AMITRIPTYLINE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTINEOPLASTIC AGENT; ANTIPARKINSON AGENT; ANTITUSSIVE AGENT; ATENOLOL; BACAMPICILLIN; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMAZEPAM; CAPTOPRIL; CAPTOPRIL PLUS HYDROCHLOROTHIAZIDE; CARBOPLATIN; CARDIOTONIC AGENT; CEFIXIME; CEFODIZIME; CEFPROZIL; CEFTRIAXONE; CHLORPHENIRAMINE; CIPROFLOXACIN; CITALOPRAM; CLARITHROMYCIN; CLEBOPRIDE; CLONAZEPAM; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DESOGESTREL; DEXTROMETHORPHAN; DIAZEPAM; DICLOFENAC; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; ENALAPRIL; ETHINYLESTRADIOL PLUS GESTODENE; FLUOXETINE; FOLIC ACID; FOSINOPRIL; FUROSEMIDE; GEMCITABINE; GLYCERYL TRINITRATE; HEPARIN; HERBACEOUS AGENT; HYDROCHLOROTHIAZIDE; INDINAVIR; INSULIN; INSULIN DERIVATIVE; ISOSORBIDE DINITRATE; KETOROLAC; LACIDIPINE; LANSOPRAZOLE; LORATADINE; LOSARTAN; METHYLPREDNISOLONE; NAPROXEN; NEUROLEPTIC AGENT; NIFEDIPINE; NIFLUMIC ACID; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PERPHENAZINE; PHENAZONE DERIVATIVE; PHENOBARBITAL; PIROXICAM; POTASSIUM CHLORIDE; PREDNISONE; QUINIDINE; RAMIPRIL; RANITIDINE; RISPERIDONE; SEX HORMONE; SILDENAFIL; SPIRAMYCIN; SPIRONOLACTONE; SUMATRIPTAN; THIOCOLCHICOSIDE; TICLOPIDINE; TIZANIDINE; TRAZODONE; VACCINE; VALPROIC ACID; VINCRISTINE; VITAMIN; WARFARIN;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; AGING; ARTICLE; ASTHENIA; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CONFUSION; DIARRHEA; DRUG INDUCED DISEASE; DRUG SURVEILLANCE PROGRAM; DYSPNEA; EDEMA; EMERGENCY WARD; ERYTHEMA; FACE EDEMA; FAINTNESS; FEMALE; FEVER; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; GENDER; HEADACHE; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; INCIDENCE; INFANT; ITALY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; METABOLIC DISORDER; MUSCULOSKELETAL DISEASE; NUTRITIONAL DISORDER; PERIPHERAL NEUROPATHY; POLYPHARMACY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; RISK FACTOR; SENSORY DYSFUNCTION; SKIN DISEASE; SYNCOPE; TACHYCARDIA; THORAX PAIN; URTICARIA; VERTIGO; VISUAL IMPAIRMENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DRUG INTERACTIONS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; ITALY; MALE; MEDICATION ERRORS; MIDDLE AGED; OUTPATIENTS; PATIENT ADMISSION; PHARMACEUTICAL PREPARATIONS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 19144368293     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.1074     Document Type: Article

References (39)

1. Begaud B, Martin K, Fourrier A, Haramburu F. Does age increase the risk of adverse drug reactions? Br J Clin Pharmacol 2002; 54: 550-552.
2. Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the elderly (GIFA). J Am Geriatr Soc 2002; 50: 1962-1968.
3. Carbonin P, Pahor M, Bernabei R, Sgadari A. Is age an independent risk factor of adverse drug reactions in hospitalised medical patients? J Am Geriatr Soc 1991; 39: 1093-1099.
4. Beard K. Adverse reactions as a cause of hospital admission in the aged. Drugs Ageing 1992; 2: 356-367.
5. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalised patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1997; 277: 301-306.
6. Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalised patients. Results of the Harvard Medical Practice Study II. N Engl J Med 1991; 324: 377-384.
7. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalised patients. Adverse Drug Events Prevention Study Group. JAMA 1997; 277: 307-311.
8. Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA 1995; 274: 35-43.
9. Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med 2003; 348: 1556-1564.
10. Hutchinson TA, Flegel KM, Kramer MS, Leduc DG, Kong HH. Frequency, severity and risk factors for adverse drug reactions in adult out-patients: a prospective study. J Chronic Dis 1986; 39: 533-542.
11. Hanlon JT, Schmader KE, Koronkowski MJ, et al. Adverse drug events in high risk older outpatients. J Am Geriatr Soc 1997; 45: 945-948.
12. Trunet P, Le Gall JR, Lhoste F, et al. The role of iatrogenic disease in admissions to intensive care. JAMA 1980; 244: 2617-2620.
13. Ghose K. Hospital bed occupancy due to drug-related problems. J R Soc Med 1980; 73: 853-856.
14. Bergman U, Wiholm BE. Drug-related problems causing admission to a medical clinic. Eur J Clin Pharmacol 1981; 20: 193-200.
15. Trunet P, Borda IT, Rouget AV, Rapin M, Lhoste F. The role of drug-induced illness in admissions to an intensive care unit. Intensive Care Med 1986; 12: 43-46.
16. Einarson TR. Drug-related hospital admissions. Ann Pharmacother 1993; 27: 832-880.
17. Garijo B, de Abajo FJ, Castro AM, Lopo CR, Carcas A, Frias J. Hospitalisations because of drugs: a prospective study. Rev Clin Esp 1991; 188: 7-12.
18. Schneeweiss S, Hasford J, Gottler M, Hoffmann A, Riethling AK, Avorn J. Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol 2002; 58: 285-291.
19. Patel P, Zed PJ. Drug-related visits to the emergency department: how big is the problem? Pharmacotherapy 2002; 22: 915-923.
20. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. Br Med J 2004; 329: 15-19.
21. Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M, Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 2001; 52: 77-83.
22. Raschetti R, Morgutti M, Menniti-Ippolito F, et al. Suspected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol 1999; 54: 959-963.
23. http://www.farmacovigilanza.org/psade/Date of access: [14 June 2004].
24. Calogero G. Proceedings of the British Pharmacological Society Clinical Pharmacology Section. Br J Clin Pharmacol 2000; 51: 363-391.
25. World Health Organisation. WHO Technical Report. 1972; 498.
26. Hafner JW, Jr., Belknap SM, Squillante MD, Bucheit KA. Adverse drug events in emergency department patients. Ann Emerg Med 2002; 39: 258-267.
27. Delamothe T. Reporting adverse drug reactions. Br Med J 1992; 304: 465.
28. Smith KM, McAdams JW, Frenia ML, Todd MW. Drug-related problems in emergency department patients. Am J Health Syst Pharm 1997; 54: 295-298.
29. Roblot P, de Bayser L, Barrier J, Marechaud R, Becq-Giraudon B. 'Primum non nocere'. Prospective study of 115 cases of iatrogenic diseases collected over one year in 106 patients. Rev Med Interne 1994; 15: 720-726.
30. Darchy B, Le Miere E, Figueredo B, Bavoux E, Domart Y. Iatrogenic diseases as a reason for admission to the intensive care unit: incidence, causes, and consequences. Arch Intern Med 1999; 159: 71-78.
31. Ponge T, Cottin S, Fruneau P, Ponge A, Van Wassenhove L, Larousse C. Iatrogenic disease. Prospective study, relation to drug consumption. Therapie 1989; 44: 63-66.
32. Domecq C, Naranjo CA, Ruiz I, Busto U. Sex-related variations in the frequency and characteristics of adverse drug reactions. Int J Clin Pharmacol Ther Toxicol 1980; 18: 362-366.
33. Olivier P, Boulbes O, Tubery M, Carles P, Montastruc JL, Lapeyre-Mestre M. Preventability of adverse effects in a medical emergency service. Therapie 2001; 56: 275-278.
34. Traversa G, Bianchi C, Da Cas R, Abraha I, Menniti-Ippolito F, Venegoni M. Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs. Br Med J 2003; 327: 18-22.
35. Hallas J, Gram LF, Grodum E, et al. Drug related admissions to medical wards: a population based survey. Br J Clin Pharmacol 1992; 33: 61-68.
36. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995; 274: 29-34.
37. Mazzaglia G, Caputi AP, Rossi A, et al. Exploring patient- and doctor-related variables associated with antibiotic prescribing for respiratory infections in primary care. Eur J Clin Pharmacol 2003; 59: 651-657.
38. Wood MJ, Stewart RL, Merry H, Johnstone DE, Cox JL. Use of complementary and alternative medical therapies in patients with cardiovascular disease. Am Heart J 2003; 145: 806-812.
39. Benichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs-II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol 1993; 46: 1331-1336.